NeolPharma RETDE 10MG | Retatrutide

  • Most advanced peptide for extreme fat loss and muscle retention
  • Green-top RETDE – the future of metabolic and body-composition research
  • Weekly injection with superior appetite and energy effects
  • The triple-threat peptide taking longevity and physique enhancement to the next level

The next-generation triple-agonist peptide – superior fat loss, muscle preservation, appetite control, and metabolic boost for unprecedented body recomposition.

NeolPharma RETDE 10 is pharmaceutical-grade Retatrutide, a triple hormone receptor agonist (GLP-1, GIP, and Glucagon) supplied as 10 mg of lyophilized powder per vial for reconstitution. This green-top vial represents the cutting-edge in weight-loss and performance peptides, combining the mechanisms of Semaglutide with enhanced glucagon activity for superior fat mobilization and energy expenditure.

Benefits

  • Exceptional fat loss (15–25%+ body weight reduction in research protocols)
  • Superior appetite suppression and craving elimination compared to single/double agonists
  • Increased energy expenditure and thermogenesis via glucagon receptor activation
  • Excellent preservation (and potential increase) of lean muscle mass
  • Improved insulin sensitivity, blood glucose control, and lipid profile
  • Enhanced satiety, better nutrient partitioning, and reduced inflammation
  • Potential for greater results than Semaglutide or Tirzepatide in body composition studies
  • Emerging as the most powerful peptide for long-term fat loss and metabolic optimization

Usage Instructions

  • Dosage: Beginners: Start at 0.5–1 mg/week – Standard: 2–4 mg/week – Advanced/Research: 4–8 mg/week (titrated slowly over 4–6 weeks)
  • Administration: Subcutaneous injection (abdomen, thigh) once weekly
  • Cycle length: 12–24+ weeks (slow titration essential to minimize side effects)
  • Reconstitution: Add 2 ml bacteriostatic water (5 mg/ml concentration) → gently swirl → refrigerate
  • Best timing: Same day each week; consistent schedule for stable blood levels
  • Storage: 2–8°C after reconstitution (stable 4–6 weeks); protect from light

Cautions

  • Common side effects: nausea, vomiting, diarrhea, constipation (minimize with very slow titration)
  • Potential for hypoglycemia, especially when combined with insulin or other glucose-lowering agents
  • May cause increased heart rate due to glucagon activity – monitor cardiovascular response
  • Contraindicated in history of medullary thyroid carcinoma or multiple endocrine neoplasia
  • Keep refrigerated; discard if solution becomes cloudy or seal is broken

Reviews

There are no reviews yet.

Be the first to review “NeolPharma RETDE 10MG | Retatrutide”

Your email address will not be published. Required fields are marked *

Scroll to Top